PGNY241220C17500
- 0.25
- 0.000.00%
Progyny Newsroom
Meridian Hedged Equity Fund Decided to Sell Its Holdings in Progyny (PGNY). Here's Why
Progyny (NASDAQ:PGNY) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Three Years, but the Stock Rallies 11% This Past Week
Here's Why Progyny (PGNY) Was Under Pressure in Q3
Health Care Roundup: Market Talk
Progyny Is Maintained at Overweight by Barclays
Progyny, Inc. to Present at Jefferies London Healthcare Conference
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $17 to $22
Progyny Price Target Lowered to $21 From $22 at BofA
Progyny CEO Says Election Didn't Contribute to Weak 3Q -- Market Talk
Progyny Isn't Sure Why Its Members Aren't Pursuing More Fertility Care -- Market Talk
Jefferies Adjusts Progyny Price Target to $19 From $24, Maintains Buy Rating
These Analysts Slash Their Forecasts On Progyny Following Q3 Results
Sector Update: Health Care Stocks Rise Premarket Wednesday
A Closer Look at 11 Analyst Recommendations For Progyny
Progyny Is Maintained at Hold by Canaccord Genuity
Progyny Price Target Cut to $17.00/Share From $18.00 by Canaccord Genuity
Sector Update: Health Care
Spirit Airlines, Groupon, ZoomInfo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $19 to $30
Progyny Share Shares Are Trading Lower After the Company Reported Worse-than-expected Q3 Sales Results and Issued Q4 and FY24 Revenue Guidance Below Estimates.